After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

For Vertex these days, it’s all about the launches of three new products—sickle cell disease gene therapy Casgevy, the ...

Vertex Pharmaceuticals is working toward making its recently approved non-opioid pain medicine Journavx not only broadly ...

Easy access and exposure to guns and drugs are killing Kentucky children, according to the Child Fatality and Near Fatality ...

Vertex Pharmaceuticals forecast annual revenue largely above Wall Street estimates on Monday, banking on robust sales of its ...

Greater pain intensity in cancer survivors correlates with increased cigarette, e-cigarette, and cannabis use, but decreased alcohol consumption. Greater pain intensity in cancer survivors has been ...

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

In a recent study, majority non-White communities had at least 40 percent lower mean adjusted per-capita distribution than majority White communities.

Experiencing pain may increase the odds that cancer survivors will use cigarettes and cannabis, according to a recent study published by Wiley online in CANCER.

U.S. Senators propose the Alternatives to PAIN Act to increase access to non-opioid pain treatments for seniors.

Their report on the Fentanyl Accountability and Prevention Act was designed to inform future decision-making...and "that ...

The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...